Psychosocial morbidity of Graves' orbitopathy
- PMID: 16181231
- DOI: 10.1111/j.1365-2265.2005.02352.x
Psychosocial morbidity of Graves' orbitopathy
Abstract
Objective: Ocular diseases markedly impair daily function. In Graves' orbitopathy (GO), an associated psychosocial burden is present due to disfiguring proptosis and/or diplopia, signs with significant impact on functional status and well-being. We have therefore surveyed and assessed the psychosocial morbidity of GO.
Design: A prospective controlled study on subjects with GO using internationally validated, self-reporting questionnaires.
Patients: One hundred and two consecutive patients with varying degrees of severity and activity of GO. Measurements Emotional distress, coping styles and quality of life (QoL) were assessed by the Hospital Anxiety and Depression Scale, by a German adaptation of the Ways-of-Coping Checklist, and with the 36-item Short Form, respectively. Stressful events in the 6 months preceding diagnosis were registered with the Life Experience Survey. QoL findings were compared to German reference values, as well as to 102 age- and gender-matched patients, each with type 1 diabetes (insulin-dependent diabetes mellitus, IDDM) and inflammatory bowel disease (IBD), respectively.
Results: Compared to the German reference population, all QoL scales were at a lower rate and were especially decreased in subjects with active and/or severe GO, orbital pain, diplopia and stressful life events. Compared to diabetics, psychosocial scales were considerably reduced in GO (z = -1 vs. 0.1, P < 0.001) and higher scores for depressive coping (2.32 vs. 1.71, P < 0.001) and trivializing (2.37 vs. 1.97, P < 0.006) were noted. In GO, depressive coping and trivializing were negatively correlated with the mental (r = -0.603 and r =-0.411, both P < 0.001) and physical (r = -0.487 and r = -0.354, both P < 0.001) components of QoL. Depressive coping also positively correlated with anxiety (r = 0.636) and depression (r = 0.590), respectively, both P < 0.001. Emotional distress noted in 46 subjects, mostly with active and severe GO, was associated with poor QoL. Anxiety and depression were present in 41 and 24 GO patients, respectively. The number of stressful events positively correlated with the scores of anxiety (r = 0.3335) and depression (r = 0.3178), both P = 0.001. Foremost emotional distress, but also diplopia, stressful events and depressive coping had a major impact on QoL (proportion of variance explained = 13.1%, P < 0.001, multiple regression analysis). More than 75% of the psychosocial impairment in GO (R2= 0.76, P < 0.001) was associated with seven variables only (e.g. depression and anxiety). Six months prior to GO onset, 74 patients experienced a mean of 4 (range 0-13) stressful life events. Subjects with optic neuropathy had more stressful events than those without nerve involvement (5.1 vs. 2.7, P = 0.0425).
Conclusions: Psychosocial morbidity is present in severe and/or active GO, which negatively affects QoL. The patients are not only physically ill, they also exhibit emotional distress. Accompanying psychosomatic treatment is indicated among about half of all GO patients.
Similar articles
-
Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function.Am J Gastroenterol. 1995 Sep;90(9):1450-4. Am J Gastroenterol. 1995. PMID: 7661168
-
Emotional distress and quality of life in caregivers of patients awaiting lung transplant.J Psychosom Res. 2005 Jul;59(1):1-6. doi: 10.1016/j.jpsychores.2005.03.007. J Psychosom Res. 2005. PMID: 16126089
-
Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis.J Psychosom Res. 2009 Nov;67(5):425-31. doi: 10.1016/j.jpsychores.2009.01.001. Epub 2009 Mar 5. J Psychosom Res. 2009. PMID: 19837205
-
Life can be worth living in locked-in syndrome.Prog Brain Res. 2009;177:339-51. doi: 10.1016/S0079-6123(09)17723-3. Prog Brain Res. 2009. PMID: 19818912 Review.
-
Efficacy and side effects of 'swinging eyelid' orbital decompression in Graves' orbitopathy: a proposal for standardized evaluation of diplopia.Eye (Lond). 2006 Feb;20(2):154-62. doi: 10.1038/sj.eye.6701827. Eye (Lond). 2006. PMID: 15746952 Review.
Cited by
-
Influence of 4-week or 12-week glucocorticoid treatment on metabolic changes in patients with active moderate-to-severe thyroid-associated ophthalmopathy.Clin Transl Sci. 2021 Sep;14(5):1734-1746. doi: 10.1111/cts.12999. Epub 2021 May 3. Clin Transl Sci. 2021. PMID: 33742766 Free PMC article.
-
Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy.Taiwan J Ophthalmol. 2022 Aug 1;12(3):325-329. doi: 10.4103/tjo.tjo_30_22. eCollection 2022 Jul-Sep. Taiwan J Ophthalmol. 2022. PMID: 36248076 Free PMC article.
-
[Endocrine ophthalmopathy. A visible psychophysical complaint].Ophthalmologe. 2016 Feb;113(2):126-30. doi: 10.1007/s00347-015-0212-6. Ophthalmologe. 2016. PMID: 26801325 German.
-
Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves' orbitopathy and analysis on who requires additional therapy.Clin Ophthalmol. 2016 Nov 17;10:2277-2289. doi: 10.2147/OPTH.S118555. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27895458 Free PMC article.
-
Canonical and Truncated Transglutaminase-2 Drive TGF-β1 Autocrine Loop to Induce Fibrosis in Graves' Orbitopathy.Invest Ophthalmol Vis Sci. 2025 May 1;66(5):22. doi: 10.1167/iovs.66.5.22. Invest Ophthalmol Vis Sci. 2025. PMID: 40358584 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources